Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Barrons.com2d agoneutral
Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly AgreementBarrons.com4d agoneutral
Novo Nordisk Stock Shrugs Off Eli Lilly Threat as Weight-Loss Pill Shines in EarningsBarrons.com4d agoneutral
Pfizer CEO Bourla Bets the Viagra Playbook Can Crack the Obesity Market24/7 Wall St.5d agoneutral
Merck’s Pipeline Could Be Its Next Big Growth Driver. Its Latest Earnings Offer a Clue.MT Newswires6d agoneutral
Berenberg Adjusts Price Target on Eli Lilly and Company to $1,570 From $1,400GuruFocus.com8d agoneutral
OmniAb Inc (OABI) (Q3 2026) Earnings Call Highlights: Lilly Deal, Raised Guidance and a Busy ...The Wall Street Journal39d agoneutral
The Next Frontier for Obesity Drugs Isn’t How Much Weight You Lose, but What KindThe Wall Street Journal39d agoneutral
Lilly’s Next-Gen Obesity Drug Helps People Lose Even More Weight in Study24/7 Wall St.42d agoneutral
Eli Lilly Just Won FDA Approval for a Once Weekly Insulin and the Stock Is Knocking on $1,200The Wall Street Journal47d agoneutral
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in TrialThe Wall Street Journal48d agoneutral
Pharmaceutical Companies Push Trump Administration to Protect China DealsBenzinga Private Markets48d agoneutral
The $15.6B Smart Ring Bet: Oura Takes On Wall Street With IPOThe Wall Street Journal48d agoneutral
Wegovy Maker Novo Looks to New Drugs to Combat Lilly, but Investors Are Unconvinced